Cargando…

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression

BACKGROUND: In a recent clinical trial examining the comparative efficacy of psilocybin therapy (PT) versus escitalopram treatment (ET) for major depressive disorder, 14 of 16 major efficacy outcome measures yielded results that favored PT, but the Quick Inventory of Depressive Symptomatology, Self-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Brandon, Erritzoe, David, Giribaldi, Bruna, Nutt, David J, Carhart-Harris, Robin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350722/ https://www.ncbi.nlm.nih.gov/pubmed/37122239 http://dx.doi.org/10.1177/02698811231167848

Ejemplares similares

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
por: Barba, Tommaso, et al.
Publicado: (2022)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

Body mass index (BMI) does not predict responses to psilocybin
por: Spriggs, Meg J, et al.
Publicado: (2022)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
por: Carhart-Harris, R. L., et al.
Publicado: (2017)

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
por: Shukuroglou, Melissa, et al.
Publicado: (2022)

Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Depressed Adolescents
por: Zhang, Wu-Yang, et al.
Publicado: (2020)

Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR(16)) questionnaire in patients with schizophrenia
por: Lako, Irene M, et al.
Publicado: (2014)

Validation of the Brazilian Portuguese version of the Quick Inventory of Depressive Symptomatology and Self-Report (QIDS-SR(16)) for the Brazilian population
por: Bandinelli, Lucas, et al.
Publicado: (2023)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
por: Roseman, Leor, et al.
Publicado: (2014)

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
por: Gabay, Anthony S., et al.
Publicado: (2018)

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
por: Carhart-Harris, Robin L, et al.
Publicado: (2017)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
por: Zeifman, Richard J., et al.
Publicado: (2023)

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
por: Spriggs, Meg J., et al.
Publicado: (2021)

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
por: Stroud, J. B., et al.
Publicado: (2017)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

The Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Patients with HBV-Related Liver Disease
por: UNGVARI, Gabor S., et al.
Publicado: (2017)

Evaluation of the Paper and Smartphone Versions of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) and the Patient Health Questionnaire-9 (PHQ-9) in Depressed Patients in China
por: Zhen, Long, et al.
Publicado: (2020)

Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality
por: Weiss, Brandon, et al.
Publicado: (2021)

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
por: Singleton, S. Parker, et al.
Publicado: (2022)

The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A(17)): A Psychometric Evaluation
por: Haley, Charlotte L, et al.
Publicado: (2023)

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
por: Forstmann, Matthias, et al.
Publicado: (2023)

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
por: Schartner, Michael M., et al.
Publicado: (2017)

The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021)

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
por: Heuschkel, Kristin, et al.
Publicado: (2020)

Was it a vision or a waking dream?
por: Carhart-Harris, Robin, et al.
Publicado: (2014)

Psychotherapy with Psilocybin for Depression: Systematic Review
por: Dawood Hristova, Jonathan Joseph, et al.
Publicado: (2023)

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
por: Carhart-Harris, Robin L, et al.
Publicado: (2021)

Case analysis of long-term negative psychological responses to psychedelics
por: Bremler, Rebecka, et al.
Publicado: (2023)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

Psilocybin-Assisted Compassion Focused Therapy for Depression
por: Pots, Wendy, et al.
Publicado: (2022)

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
por: Nygart, Victoria Amalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mntbotdu1vhgblct90rghqhmgo